Certolizumab use in pregnancy

Gut

Volumn 58, Issue 4, 2009, Pages 608-

  Oussalah, A ^a   Bigard, M A ^a   Peyrin Biroulet, L ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; INFLIXIMAB;

ADULT; ANGIONEUROTIC EDEMA; CASE REPORT; COLON CROHN DISEASE; DISEASE EXACERBATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FIRST TRIMESTER PREGNANCY; GENITAL BLEEDING; HUMAN; LETTER; PREGNANCY; PRIORITY JOURNAL; PSORIASIS; THIRD TRIMESTER PREGNANCY;

CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; POLYETHYLENE GLYCOLS; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 63849241563     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.166884     Document Type: Letter

References (4)

1. Vasiliauskas EA, Church JA, Silverman N, et al. Case report: evidence for transplacental transfer of meternally administered infliximab to the newborn. Clin Gastroenterol Hepetol 2006;4:1255-8.
2. Roux CH, Brocq O, Breuil V, et al. Pregnancy in rheumetology petients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumetology (Oxford) 2007;46:695-8.
3. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003;21:3365-9.
4. Stephens P, Nesbitt A, Foulkes R. Placental transfer of the anti-TNF antibody TN3 in rets: comparison of immunoglobulin G1 and pegyleted Fab versions. Gut 2006;55(Suppl):A8.